Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/43443

OpenURL Link
Title
Clinical perspectives on hereditary hemochromatosis
Author/Creator
Ayonrinde, Oyekoya T.;  Milward, Elizabeth A.;  Chua, Anita C. G.;  Trinder, Debbie;  Olynyk, John K.
Institution
The University of Newcastle. Faculty of Health, School of Biomedical Sciences and Pharmacy
Description
Hereditary hemochromatosis (HH) comprises a group of inherited disorders of iron metabolism that can result in progressive iron overload, morbidity, and mortality, generally in adulthood. HFE-related HH is the most common type of HH and will form the core of this discussion. The discovery of new proteins and gene mutations has defined other types of HH, termed non-HFE HH. The regulatory protein hepcidin has a central role in iron homeostasis in these disorders. While the liver is the predominant organ of iron deposition and iron-overload-related disease in HFE-related HH, involvement of extrahepatic tissue can also result in morbidity and mortality if the disorder is not diagnosed before organ damage develops. This review traverses the road from HFE genotype to phenotype with a focus on clinical penetrance, modifier factors for disease expression, and current thoughts and controversies on HH diagnosis and screening.
Relation
Critical Reviews in Clinical Laboratory Sciences Vol. 45, Issue 5, p. 451-484
Publisher Link
http://dx.doi.org/10.1080/10408360802335716
Date
2008
Publisher
Informa Healthcare
Keyword(s)
cancer;  cirrhosis;  phenotype;  clinical expression;  genotype;  hemochromatosis;  hepatic iron concentration;  hepcidin;  HFE;  iron;  liver
Resource Type
journal article
Identifier
http://hdl.handle.net/1959.13/43443
Identifier
ISSN:1040-8363
Reviewed
Reviewed
24 Visitors 29 Hits 0 Downloads
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Critical Reviews in Clinical Laboratory Sciences"
 
OR